Transforming the Lipid Disorder Treatment Market in 2025: Impact Of Obesity And High Cholesterol On The Lipid Disorder Treatment Market

"What Is the Expected Size and Growth Rate of the Lipid Disorder Treatment Market?
The market size for lipid disorder treatments has been expanding swiftly over the previous years. It's projected that its worth will increase from $10.69 billion in 2024 to $12.09 billion in 2025, marking a compound annual growth rate (CAGR) of 13.2%. The historic growth is due to factors such as the adoption of a sedentary lifestyle, a growing working-age population, heightened awareness about the disease and its treatments, an increase in desk jobs, and the rising incidence of familial combined hyperlipidemia.

Anticipations are that the market for lipid disorder treatment will experience precipitous expansion in upcoming years, ballooning to $19.56 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%. The ascension in this forecast duration can be traced back to escalating instances of obesity and high cholesterol, a surge in cardiovascular diseases, increasing incidents of heart diseases stemming from high cholesterol, and a rise in requests for effective and reliable treatments. Moreover, excessive intake of alcohol and smoking also contribute to the market growth. The forecast period is likely to observe significant trends such as advancements in medication creation, groundbreaking product developments, augmented investments in business extensions, innovation in treatment facilities, and numerous clinical breakthroughs.

What Is Driving the Growth Trajectory of the Lipid Disorder Treatment Market?
The escalation in obesity and high cholesterol rates is predicted to drive the expansion of the lipid disorder treatment market in the future. Obesity, associated with an excessive storage of body fat, and high cholesterol, linked to high levels of cholesterol in the blood, both contribute to serious health complications. These conditions are increasingly prevalent due to factors such as unhealthy dietary habits, lack of physical activity, genetic factors, and environmental aspects. The role of lipid disorder treatment is crucial in managing obesity and high cholesterol through a blend of drug-based interventions, lifestyle changes, weight control measures, patient awareness, and collaborative care. For instance, the World Obesity Atlas 2022, released by the UK-based non-profit entity, World Obesity Federation, in May 2022, predicted that by 2030, one billion people worldwide, including one in every five women and one in every seven men, will suffer from obesity, a figure that is projected to rise to 4 billion, or 51% of the world's population, by 2035. Thus, the escalating rates of obesity and high cholesterol are fuelling the expansion of the lipid disorder treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15600&type=smp

Which Leading Companies Are Shaping the Growth of the Lipid Disorder Treatment Market?
Major companies operating in the lipid disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Fresenius SE & Co. KGaA, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline Plc, Wockhardt Ltd., Eli Lilly and Company, Amgen Inc., Boehringer-Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Kaneka Corporation, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, Kowa Pharmaceuticals America Inc., Concord Biotech Limited, Biocon Ltd., Ranbaxy Laboratories Limited

What Are the Major Trends Shaping the Lipid Disorder Treatment Market?
Top firms in the lipid disorder treatment industry are channeling their efforts towards creating proprotein convertase subtilisin type 9 (PCSK9) inhibitors to cater to the demand for more efficient, specialized treatments for high cholesterol control. PCSK9 inhibitors play a key role in lipid regulation by enhancing the removal of LDL cholesterol from the blood, thereby lessening cardiovascular risk in high-risk patients. For illustration, in March 2024, US biotech firm Regeneron Pharmaceuticals Inc. obtained authorization for Praluent (alirocumab) injection from the U.S. Food and Drug Administration (FDA) to treat heterozygous familial hypercholesterolemia (HeFH) in children aged 8 and upwards. What sets Praluent injection apart is its capacity to block PCSK9 from binding to the LDL receptor, thus increasing the number of LDL receptors on liver cell surfaces that consequently aids LDL clearance and lowers LDL-C levels in the blood.

What Are the Key Segments of the Lipid Disorder Treatment Market?
The lipid disorder treatment market covered in this report is segmented -

1) By Drug Type: Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Other Drugs
2) By Indication: Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Atorvastatin: Generic Atorvastatin, Brand-Name Atorvastatin ( Lipitor)
2) By Fluvastatin: Generic Fluvastatin, Brand-Name Fluvastatin ( Lescol)
3) By Rosuvastatin: Generic Rosuvastatin, Brand-Name Rosuvastatin ( Crestor)
4) By Simvastatin: Generic Simvastatin, Brand-Name Simvastatin ( Zocor)
5) By Pravastatin: Generic Pravastatin, Brand-Name Pravastatin ( Pravachol)
6) By Other Drugs: Ezetimibe, Pcsk9 Inhibitors ( Alirocumab, Evolocumab), Fibrates ( Gemfibrozil, Fenofibrate), Niacin (Vitamin B3), Omega-3 Fatty Acids ( Icosapent Ethyl)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Which Region Dominates the Lipid Disorder Treatment Market?
North America was the largest region in the lipid disorder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Lipid Disorder Treatment Global Market Report?

- Market Size Analysis: Analyze the Lipid Disorder Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Lipid Disorder Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Lipid Disorder Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Lipid Disorder Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15600

"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.